These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 11190903

  • 1. Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques.
    Demir M, Iqbal O, Untch B, Hoppensteadt DA, Gaikwad BS, Fareed J.
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):38-43. PubMed ID: 11190903
    [Abstract] [Full Text] [Related]

  • 2. Anticoagulant and antiprotease profiles of a novel natural heparinomimetic mannopentaose phosphate sulfate (PI-88).
    Demir M, Iqbal O, Hoppensteadt DA, Piccolo P, Ahmad S, Schultz CL, Linhardt RJ, Fareed J.
    Clin Appl Thromb Hemost; 2001 Apr; 7(2):131-40. PubMed ID: 11292191
    [Abstract] [Full Text] [Related]

  • 3. Monitoring of anticoagulant effects of direct thrombin inhibitors.
    Fenyvesi T, Jörg I, Harenberg J.
    Semin Thromb Hemost; 2002 Aug; 28(4):361-8. PubMed ID: 12244483
    [Abstract] [Full Text] [Related]

  • 4. Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay.
    Pötzsch B, Hund S, Madlener K, Unkrig C, Müller-Berghaus G.
    Thromb Res; 1997 Jun 01; 86(5):373-83. PubMed ID: 9211628
    [Abstract] [Full Text] [Related]

  • 5. The use of PEG-Hirudin in chronic hemodialysis monitored by the Ecarin Clotting Time: influence on clotting of the extracorporeal system and hemostatic parameters.
    Ulbricht K, Bucha E, Pöschel KA, Stein G, Wolf G, Nowak G.
    Clin Nephrol; 2006 Mar 01; 65(3):180-90. PubMed ID: 16550749
    [Abstract] [Full Text] [Related]

  • 6. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.
    Gosselin RC, King JH, Janatpour KA, Dager WE, Larkin EC, Owings JT.
    Ann Pharmacother; 2004 Sep 01; 38(9):1383-8. PubMed ID: 15238620
    [Abstract] [Full Text] [Related]

  • 7. Ecarin clotting time but not aPTT correlates with PEG-hirudin plasma activity.
    Moser M, Ruef J, Peter K, Kohler B, Gulba DC, Paterna N, Nordt T, Kübler W, Bode C.
    J Thromb Thrombolysis; 2001 Oct 01; 12(2):165-9. PubMed ID: 11729368
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modified plasma-based ecarin clotting time assay for monitoring of recombinant hirudin during cardiac surgery.
    Choi TS, Khan AI, Greilich PE, Kroll MH.
    Am J Clin Pathol; 2006 Feb 01; 125(2):290-5. PubMed ID: 16393689
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA, Blajchman MA, Modi GJ, Smith LM, Buchanan MR, Hirsh J.
    Br J Haematol; 1985 Aug 01; 60(4):695-704. PubMed ID: 2411283
    [Abstract] [Full Text] [Related]

  • 18. Vasoflux, a new anticoagulant with a novel mechanism of action.
    Weitz JI, Young E, Johnston M, Stafford AR, Fredenburgh JC, Hirsh J.
    Circulation; 1999 Feb 09; 99(5):682-9. PubMed ID: 9950667
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.